MiR-148a-3p was selectively upregulated in patients with atherosclerosis and its overexpression promoted proliferation and migration, while inhibiting apoptosis via FOXO4 and FOXO3 modulation [14], as well as counteracted the release of inflammatory factors in endothelial cells [15]. This evidence concerns the gene FOXO4 and atherosclerosis.